Financial news
The newsroom
Headlines from the Federal Reserve, ECB, Bank of Japan, Bank of England, SEC EDGAR, the White House and the DOJ. Context notes are written automatically by software from each headline, not by an editor. They are neutral and information-only, Kresmion publishes no buy or sell recommendations.
Public RSS feeds · refreshed every 30 minutes
8354 items from SEC EDGAR · clear filters
- 8-K - Commerce.com, Inc. (0001626450) (Filer)
Automated noteCommerce.com, Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and providing its financial statements and related exhibits.
- 8-K - OPEN TEXT CORP (0001002638) (Filer)
Automated noteOpen Text Corp filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition (Item 2.02), other events (Item 8.01), and accompanying financial statements and exhibits (Item 9.01).
- 8-K - Zoetis Inc. (0001555280) (Filer)
Automated noteZoetis Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition (Item 2.02) and providing its financial statements and related exhibits (Item 9.01).
- 8-K - Cullinan Therapeutics, Inc. (0001789972) (Filer)
Automated noteCullinan Therapeutics filed a Form 8-K on August 6, 2026, including Item 2.02 on results of operations and financial condition and Item 9.01 containing financial statements and exhibits.
- 8-K - Vistance Networks, Inc. (0001517228) (Filer)
Automated noteVistance Networks filed a Form 8-K reporting departures and appointments of officers and directors, related compensatory arrangements, other events, and accompanying financial statements and exhibits.
- 8-K - Smith Douglas Homes Corp. (0001982518) (Filer)
Automated noteSmith Douglas Homes Corp. filed a Form 8-K on August 6, 2026, including Item 2.02 detailing its results of operations and financial condition, and Item 9.01 providing its financial statements and related exhibits.
- 8-K - Shift4 Payments, Inc. (0001794669) (Filer)
Automated noteShift4 Payments, Inc. filed a Form 8-K on August 6, 2026, including Item 2.02 on results of operations and financial condition and Item 9.01 containing financial statements and exhibits.
- 8-K - Core Natural Resources, Inc. (0001710366) (Filer)
Automated noteCore Natural Resources, Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition, providing a Regulation FD disclosure, and attaching financial statements and related exhibits.
- 8-K - BENTLEY SYSTEMS INC (0001031308) (Filer)
Automated noteBentley Systems Inc. filed a Form 8-K on August 6, 2026, disclosing its results of operations and financial condition and attaching its financial statements and related exhibits.
- 8-K - Resolute Holdings Management, Inc. (0002039497) (Filer)
Automated noteResolute Holdings Management, Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and including its financial statements and related exhibits.
- 8-K - IOVANCE BIOTHERAPEUTICS, INC. (0001425205) (Filer)
Automated noteIovance Biotherapeutics filed a Form 8-K on August 6, 2026, reporting results of operations and financial condition (Item 2.02) and providing financial statements and exhibits (Item 9.01).
- 8-K - Tecnoglass Holdings Inc. (0001534675) (Filer)
Automated noteTecnoglass Holdings Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition (Item 2.02) and providing its financial statements and exhibits (Item 9.01).
- 8-K - BlackSky Technology Inc. (0001753539) (Filer)
Automated noteBlackSky Technology Inc. filed a Form 8-K on August 6, 2026 (Accession No. 0001753539-26-000118), reporting its results of operations and financial condition and providing its financial statements and related exhibits.
- 8-K - Vital Farms, Inc. (0001579733) (Filer)
Automated noteVital Farms, Inc. filed a Form 8-K reporting entry into and termination of material definitive agreements, disclosed its results of operations and financial condition, created a direct financial obligation/off-balance-sheet arrangement, and provided related financial statements and exhibits.
- 8-K - Viridian Therapeutics, Inc.\DE (0001590750) (Filer)
Automated noteViridian Therapeutics, Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and including its financial statements and related exhibits.
- 8-K - LIGAND PHARMACEUTICALS INC (0000886163) (Filer)
Automated noteLigand Pharmaceuticals Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and providing its financial statements and related exhibits.
- 8-K - Opus Genetics, Inc. (0001228627) (Filer)
Automated noteOpus Genetics, Inc. filed a Form 8-K on August 6, 2026, including Item 2.02 covering its results of operations and financial condition and Item 9.01 containing its financial statements and exhibits.
- 8-K - Korro Bio, Inc. (0001703647) (Filer)
Automated noteKorro Bio, Inc. filed a Form 8-K reporting a material definitive agreement, its results of operations and financial condition, unregistered sales of equity securities, and accompanying financial statements and exhibits.
- 8-K - Warner Bros. Discovery, Inc. (0001437107) (Filer)
Automated noteWarner Bros. Discovery, Inc. filed a Form 8-K on August 6, 2026, including Item 2.02 (results of operations and financial condition), Item 7.01 (Regulation FD disclosure), and Item 9.01 (financial statements and exhibits).
- 8-K - Monte Rosa Therapeutics, Inc. (0001826457) (Filer)
Automated noteMonte Rosa Therapeutics, Inc. filed a Form 8-K on August 6, 2026, including Item 2.02 results of operations and financial condition and Item 9.01 financial statements and exhibits.
- 8-K - Evolent Health, Inc. (0001628908) (Filer)
Automated noteEvolent Health, Inc. filed a Form 8-K on August 6, 2026 (Accession No. 0001628908-26-000084) containing Item 2.02 on results of operations and financial condition and Item 9.01 with its financial statements and exhibits.
- 8-K - Cartesian Therapeutics, Inc. (0001453687) (Filer)
Automated noteCartesian Therapeutics, Inc. filed a Form 8-K on August 6, 2026, reporting results of operations and financial condition and including its financial statements and related exhibits.
- 8-K - GPGI, Inc. (0001823144) (Filer)
Automated noteGPGI, Inc. submitted a Form 8-K on August 6, 2026, reporting results of operations and financial condition, other events, and accompanying financial statements and exhibits, under accession number 0001628280-26-053821.
- 8-K - NEXSTAR MEDIA GROUP, INC. (0001142417) (Filer)
Automated noteNexstar Media Group, Inc. filed a Form 8-K on August 6, 2026, including Item 2.02 covering results of operations and financial condition, and Item 9.01 containing its financial statements and related exhibits.
- 8-K - Unity Software Inc. (0001810806) (Filer)
Automated noteUnity Software Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations, financial condition, and accompanying financial statements and exhibits.
- 8-K - FS KKR Capital Corp (0001422183) (Filer)
Automated noteFS KKR Capital Corp filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition, providing a Regulation FD disclosure, and attaching its financial statements and related exhibits.
- 8-K - NexPoint Real Estate Finance, Inc. (0001786248) (Filer)
Automated noteNexPoint Real Estate Finance, Inc. filed a Form 8-K on August 6, 2026, reporting Item 2.02 results of operations and financial condition and Item 9.01 financial statements and exhibits.
- 8-K - SOMNIGROUP INTERNATIONAL INC. (0001206264) (Filer)
Automated noteSomniGroup International Inc. filed a Form 8-K on August 6, 2026 (Accession No. 0001206264-26-000099, 983 KB), reporting Item 2.02 results of operations and financial condition, Item 8.01 other events, and Item 9.01 financial statements and exhibits.
- 8-K - Atlantic Union Bankshares Corp (0000883948) (Filer)
Automated noteAtlantic Union Bankshares Corp filed an 8-K on August 6, 2026, containing a Regulation FD disclosure and financial statements with related exhibits.
- 8-K - Zai Lab Ltd (0001704292) (Filer)
Automated noteZai Lab Ltd filed a Form 8-K on August 6, 2026, including Item 2.02 reporting its results of operations and financial condition, and Item 9.01 containing its financial statements and related exhibits.